CSF beta-endorphin and leu-enkephalin levels in the acute and chronic stages of cerebral infarction.
To investigate the role of endogenous opioid peptides in the pathophysiology of cerebral ischaemia, the CSF levels of immunoreactive beta-endorphin and leu-enkephalin in 16 patients with cerebral infarction were measured. Both the CSF beta-endorphin and leu-enkephalin levels in the acute stage of cerebral infarction were significantly higher than the values in the chronic stage. The CSF concentrations of the two peptides revealed a positive correlation in the acute but not the chronic stage. The increased endogenous opioid peptides in the CSF in the acute stage may modify the evolution of cerebral infarction.
D000208:Acute Disease; D000368:Aged; D002544:Cerebral Infarction / Q000134:cerebrospinal fluid*; D002908:Chronic Disease; D004723:Endorphins / Q000134:cerebrospinal fluid*; D004743:Enkephalin, Leucine / Q000134:cerebrospinal fluid*; D006801:Humans; D008875:Middle Aged; D011863:Radioimmunoassay; D001615:beta-Endorphin
D004723:Endorphins; D004743:Enkephalin, Leucine; D001615:beta-Endorphin